The results suggest that compounds derived from C. lancifolius, particularly Alnusiin, may serve as potential inhibitors of CASP3 and STAT3 proteins in hepatocellular carcinoma (HCC) and could be explored for the development of improved anti-HCC therapeutics. This evidence concerns the gene CASP3 and hepatocellular carcinoma.